Cabozantinib, a New Standard of Care for Patients With Advanced Renal Cell Carcinoma and Bone Metastases? Subgroup Analysis of the METEOR Trial - Escudier, B; Powles, T; Motzer, RJ (J Clin Oncol, 2018)
et al.